HK1061641A1 - Antacid and laxative tablets - Google Patents

Antacid and laxative tablets

Info

Publication number
HK1061641A1
HK1061641A1 HK04104531A HK04104531A HK1061641A1 HK 1061641 A1 HK1061641 A1 HK 1061641A1 HK 04104531 A HK04104531 A HK 04104531A HK 04104531 A HK04104531 A HK 04104531A HK 1061641 A1 HK1061641 A1 HK 1061641A1
Authority
HK
Hong Kong
Prior art keywords
tablet
oxide particles
magnesium oxide
antacid
laxative
Prior art date
Application number
HK04104531A
Other languages
English (en)
Inventor
Mitsuhiro Sofue
Isamu Kawamura
Shigeo Yamao
Hideaki Baba
Shiro Horie
Yoko Abe
Hisae Sofue
Original Assignee
Kyowa Chem Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Chem Ind Co Ltd filed Critical Kyowa Chem Ind Co Ltd
Publication of HK1061641A1 publication Critical patent/HK1061641A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK04104531A 2001-08-27 2004-06-24 Antacid and laxative tablets HK1061641A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001256421 2001-08-27
PCT/JP2002/006909 WO2003018034A1 (fr) 2001-08-27 2002-07-08 Comprimes antiacides et laxatifs

Publications (1)

Publication Number Publication Date
HK1061641A1 true HK1061641A1 (en) 2004-09-30

Family

ID=19084237

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04104531A HK1061641A1 (en) 2001-08-27 2004-06-24 Antacid and laxative tablets

Country Status (18)

Country Link
US (1) US7147868B2 (fr)
EP (1) EP1421944B1 (fr)
KR (3) KR100972773B1 (fr)
CN (1) CN1262278C (fr)
AT (1) ATE380546T1 (fr)
AU (1) AU2002318630B2 (fr)
CA (1) CA2424554C (fr)
DE (1) DE60224056T2 (fr)
DK (1) DK1421944T3 (fr)
ES (1) ES2296960T3 (fr)
HK (1) HK1061641A1 (fr)
MX (1) MXPA03003292A (fr)
MY (1) MY134676A (fr)
NO (1) NO333440B1 (fr)
PT (1) PT1421944E (fr)
RU (1) RU2284189C2 (fr)
TW (1) TWI331044B (fr)
WO (1) WO2003018034A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
US20050220865A1 (en) * 2004-04-02 2005-10-06 Koleng John J Compressed composition comprising magnesium salt
US20060165759A1 (en) * 2005-01-27 2006-07-27 Warner-Lambert Company Llc Antacid lozenge containing micronized particles
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
CN101835478B (zh) * 2007-10-29 2012-12-26 协和化学工业株式会社 缓泻剂
WO2010098417A1 (fr) * 2009-02-25 2010-09-02 協和化学工業株式会社 Fins granules d'oxyde de magnésium
EP2422771A4 (fr) * 2009-04-22 2014-02-19 Kyowa Chem Ind Co Ltd Comprimé et pilons pour celui-ci
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
BR112012005163A2 (pt) * 2009-09-08 2016-05-03 Kyowa Chem Ind Co Ltd comprimido antiácido e laxante compreendendo partículas de óxido de magnésio, processo para produzir um comprimido antiácido e laxante, e, uso do comprimido
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
CN102283861A (zh) * 2010-06-17 2011-12-21 杭州赛利药物研究所有限公司 氢氧化镁在制药中的用途以及氢氧化镁制剂和制备方法
PL395069A1 (pl) * 2011-05-31 2012-12-03 Warszawski Uniwersytet Medyczny Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego
JP2014224080A (ja) * 2013-05-17 2014-12-04 協和化学工業株式会社 大腸の検査または手術のための処置剤
JP6343338B2 (ja) 2014-02-25 2018-06-13 神島化学工業株式会社 医薬用又は食品添加用酸化マグネシウム顆粒
CN108686222B (zh) * 2018-06-13 2021-03-19 合肥合源药业有限公司 瑞舒伐他汀钙组合物的制备方法
TWI724629B (zh) * 2018-11-16 2021-04-11 日商協和化學工業股份有限公司 緩瀉用錠劑
CN111281855B (zh) * 2020-03-23 2021-09-24 乐普制药科技有限公司 一种雷贝拉唑肠溶片及其制备方法
CN115487160A (zh) * 2022-09-27 2022-12-20 威海百合生物技术股份有限公司 一种氧化镁片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000051A1 (fr) * 1986-06-24 1988-01-14 Racz Istvan Procede pour la production de preparations pharmaceutiques ayant une capacite elevee de liaison de l'acide gastrique, un effet retarde et une biodisponibilite accrue
JP2731854B2 (ja) * 1989-02-10 1998-03-25 協和化学工業株式会社 高耐水和性、高流動性酸化マグネシウムの製造方法
DE3937455A1 (de) * 1989-11-10 1991-05-16 Nordmark Arzneimittel Gmbh Antacidatabletten
IT1250701B (it) 1991-07-24 1995-04-21 Angelini Francesco Ist Ricerca Composizione farmaceutica solida per uso orale a base di dapiprazolo
JP2711614B2 (ja) * 1992-06-10 1998-02-10 新日本製鐵株式会社 皮膜特性及び磁気特性の優れた方向性電磁鋼板の製造方法
JPH0940561A (ja) * 1995-08-02 1997-02-10 Fujitsukusu Kk 瀉下剤
JPH10120416A (ja) * 1996-10-17 1998-05-12 Kyowa Chem Ind Co Ltd 水懸濁用水酸化マグネシウム粉末
JP2000001428A (ja) * 1998-04-16 2000-01-07 Nippon Shinyaku Co Ltd 錠剤及び製造法
JP2001048792A (ja) * 1998-11-26 2001-02-20 Fujix Kk 瀉下剤

Also Published As

Publication number Publication date
DE60224056T2 (de) 2008-12-04
NO20031873D0 (no) 2003-04-25
KR20090065552A (ko) 2009-06-22
TWI331044B (en) 2010-10-01
KR100972773B1 (ko) 2010-07-30
KR20080099353A (ko) 2008-11-12
EP1421944A4 (fr) 2005-08-31
DE60224056D1 (de) 2008-01-24
EP1421944B1 (fr) 2007-12-12
US7147868B2 (en) 2006-12-12
US20040022872A1 (en) 2004-02-05
NO20031873L (no) 2003-04-25
EP1421944A1 (fr) 2004-05-26
CN1473049A (zh) 2004-02-04
MY134676A (en) 2007-12-31
WO2003018034A1 (fr) 2003-03-06
DK1421944T3 (da) 2008-03-31
ATE380546T1 (de) 2007-12-15
RU2284189C2 (ru) 2006-09-27
KR20040044385A (ko) 2004-05-28
PT1421944E (pt) 2008-01-03
CA2424554C (fr) 2009-08-18
NO333440B1 (no) 2013-06-03
ES2296960T3 (es) 2008-05-01
AU2002318630B2 (en) 2007-05-17
CA2424554A1 (fr) 2003-03-06
CN1262278C (zh) 2006-07-05
MXPA03003292A (es) 2004-12-13

Similar Documents

Publication Publication Date Title
HK1061641A1 (en) Antacid and laxative tablets
NZ548351A (en) Direct compression formulation and process
HUP0003897A2 (hu) Pezsgő sav-bázis párt tartalmazó gyógyászati kompozíciók
UA63993C2 (uk) Фармацевтична лікарська форма, що швидко тане в роті (варіанти) та спосіб формування гранул
ES2110212T3 (es) Composicion farmaceutica efervescente que contiene ibuprofeno y su procedimiento de preparacion.
SA94150373B1 (ar) أقراص دواء من الباروكسيتين paroxetine وعملية لتحضيرها
RU2004118709A (ru) Составы, содержащие азитромицин, поддающиеся прямому прессованию
HK1073263A1 (en) A process for the preparation of tablets from pharmaceutically active substances having unfavourabletabletting properties with a granulating liquid c omprising microcrystalline cellulose
KR920005979A (ko) 다공성 입자를 함유한 맛이 우수한 제약조성물 및 그 제약조성물의 제조방법
RU2003112224A (ru) Антацидная и слабительная таблетка
WO2011030659A1 (fr) Comprimé antiacide et laxatif
MY127350A (en) Flash-melt oral dose formulations
DE69518237T2 (de) Feste pharmazeutische zubereitung mit (s)-2-(4-isobutylphenyl)propionsäure als wirkstoff und mikrokristalliner cellulose und kolloidalem silica als hilfstoff
EP0105952A1 (fr) Composition bactéricide pour la fabrication de tablettes
CA2454449A1 (fr) Composition de matiere de charge synergique pour copolymeres pvp-va et cellulose microcristalline silicifie pour pastilles pharmaceutiques
CA2421769A1 (fr) 2,2-dibromo-3-nitrilopropionamide compact
ES2059260A1 (es) Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
AU632376B2 (en) Pressing not delayed release of active compound, process for its production and use of polyhydroxybutyric acid for the production of such a pressing
AU2011273595B2 (en) Compositions with a high active ingredient fraction of a mixture of chondroitin sulphate and glucosamine
BG108956A (en) A process for the preparation of tablets from pharmaceutically active substances having unfavourable tabletting properties with a granulating liquid comprising macrocrystalline cellulose
CA2297673A1 (fr) Compositions pharmaceutiques contenant un couple acide-base effervescent

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170708